Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.
Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
As dexamethasone adds indications, a study confirms efficacy of punctal occlusion for allergic conjunctivitis.
When it comes to the sexes in the operating room, the key is collaboration, with a goal of presenting patient suffering.
Higher levels of 3 macular pigments minimize risk of age-related disease.
Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Drops can simplify dosing, improving adherence and ocular surface health
Nicole Fram, MD concludes this series on the potential of decentration and subsequent IOLs misalignment, highlighting zero and negative spherical aberration lens options for these unique cases.
Expert panelists provide an overview of current unmet needs in wet AMD care and discuss the potential for improving clinical outcomes and treatment burden.
John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
Andrew G. Lee, MD, has had direct experience as being an in-flight physician over 15 times on international and domestic flights and answers some of the most frequently asked questions about being the doctor on the plane.
RWO is hosting its 5th virtual, interactive conference titled “Top 10 Things I Wish I Knew Sooner” on Saturday September 30, 2023, from 8 am to 5:30 pm Central Time.
For clinicians, the evolution of treatment is as much a responsibility as an opportunity.
Steps to take when a patient does not have a cataract.
Unique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.
Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.
New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.
Enhance your ophthalmology skills with expert tips from RWO podcast. Match procedures to patients, seek guidance, review surgical notes, practice patience, and be honest with patients.
Language can drive understanding, trust, and better outcomes for patients
Recent reports of retinal atrophy have raised concerns on potential long-term safety.
The 1-time, intracameral injection is a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction.
Corneal wound burn is a critical, yet often overlooked, complication in cataract surgery. Recognizing early signs is crucial.
Staying current on phaco technology can help surgeons provide better outcomes.
The implantable lenses can offer an advantage over laser surgery.
Patients considered vitamin D deficient had a risk of noninfectious uveitis more than twice that of their counterparts without vitamin D deficiency.
Following the CRL from the FDA last year, Aldeyra is planning to initiate a dry eye chamber clinical trial in the first half of 2024.
There’s no shortage of diet programs—Paleo, Mediterranean, intermittent fasting—all claiming to be the best option for a healthy life. Research has shown that poor lifestyle choices, including unhealthy diets, contribute to many diseases and that simply adhering to good nutrition can even prevent some health issues.